Written answers
Tuesday, 30 April 2024
Department of Health
Health Services
David Cullinane (Waterford, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
734. To ask the Minister for Health the reason public funding of CAR-T immunotherapy for leukaemia patients is limited to under 26 years of age; if consideration has been given to extending the age for funding of treatment option to beyond the age of 26 years; and if he will make a statement on the matter. [19441/24]
Mark Ward (Dublin Mid West, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
741. To ask the Minister for Health the reason public funding of CAR-T immunotherapy for leukaemia patients is limited to under 26 years old; if consideration has been given to extending the age for funding of treatment option to beyond the age of 26 years; and if he will make a statement on the matter. [19470/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 734 and 741 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments